DEVELOPING SCIENCE, DELIVERING THERAPIES Trademark

Trademark Overview


On Tuesday, May 25, 2021, a trademark application was filed for DEVELOPING SCIENCE, DELIVERING THERAPIES with the United States Patent and Trademark Office. The USPTO has given the DEVELOPING SCIENCE, DELIVERING THERAPIES trademark a serial number of 90732209. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 10, 2023. This trademark is owned by 4D Pharma PLC. The DEVELOPING SCIENCE, DELIVERING THERAPIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceuticals, namely, live biotherapeutics for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of cancer; pharmaceuticals, namely, live biotherapeutics for the treatment of gastrointestinal diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of central nervous system diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; pharmaceutical preparations of microorganisms for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases

Scientific research and development; pharmaceutical research and development; microbiology research and development into live biotherapeutics
developing science, delivering therapies

General Information


Serial Number90732209
Word MarkDEVELOPING SCIENCE, DELIVERING THERAPIES
Filing DateTuesday, May 25, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and Servicespharmaceuticals, namely, live biotherapeutics for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of cancer; pharmaceuticals, namely, live biotherapeutics for the treatment of gastrointestinal diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of central nervous system diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; pharmaceutical preparations of microorganisms for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases
Goods and ServicesScientific research and development; pharmaceutical research and development; microbiology research and development into live biotherapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code042
First Use Anywhere DateMonday, October 7, 2019
First Use In Commerce DateMonday, October 7, 2019

Trademark Owner History


Party Name4D Pharma PLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeeds LS12JZ
GB

Party Name4D Pharma PLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeeds LS12JZ
GB

Trademark Events


Event DateEvent Description
Monday, July 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, June 5, 2023WITHDRAWAL OF ATTORNEY GRANTED
Monday, June 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 6, 2022SOU EXTENSION 1 FILED
Tuesday, December 6, 2022TEAS EXTENSION RECEIVED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION WRITTEN
Monday, February 7, 2022ASSIGNED TO EXAMINER
Thursday, August 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 11, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 28, 2021NEW APPLICATION ENTERED